News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,363 Results
Type
Article (42047)
Company Profile (270)
Press Release (690029)
Multimedia
Podcasts (90)
Webinars (21)
Section
Business (205616)
Career Advice (2047)
Deals (35624)
Drug Delivery (129)
Drug Development (81649)
Employer Resources (173)
FDA (16532)
Job Trends (15042)
News (347854)
Policy (32853)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2640)
Academic (1)
Accelerated approval (45)
Adcomms (26)
Allergies (169)
Alliances (49878)
ALS (207)
Alzheimer's disease (1774)
Antibody-drug conjugate (ADC) (430)
Approvals (16900)
Artificial intelligence (641)
Autoimmune disease (267)
Automation (52)
Bankruptcy (364)
Best Places to Work (11664)
BIOSECURE Act (20)
Biosimilars (219)
Biotechnology (179)
Bladder cancer (185)
Brain cancer (70)
Breast cancer (734)
Cancer (5705)
Cardiovascular disease (457)
Career advice (1735)
Career pathing (42)
CAR-T (319)
CDC (55)
Celiac Disease (3)
Cell therapy (857)
Cervical cancer (46)
Clinical research (70733)
Collaboration (2024)
Company closure (5)
Compensation (1359)
Complete response letters (77)
COVID-19 (2753)
CRISPR (106)
C-suite (1085)
Cystic fibrosis (150)
Data (7625)
Decentralized trials (3)
Denatured (27)
Depression (157)
Dermatology (80)
Diabetes (580)
Diagnostics (6927)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (311)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (274)
Earnings (91660)
Editorial (64)
Employer branding (21)
Employer resources (152)
Events (119551)
Executive appointments (1068)
FDA (20167)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1701)
Gene editing (229)
Generative AI (54)
Gene therapy (694)
GLP-1 (1043)
Government (4747)
Grass and pollen (6)
Guidances (404)
Healthcare (19007)
HIV (78)
Huntington's disease (56)
IgA nephropathy (94)
Immunology and inflammation (283)
Immuno-oncology (88)
Indications (178)
Infectious disease (3092)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (286)
Interviews (321)
IPO (16677)
IRA (50)
Job creations (3683)
Job search strategy (1443)
JPM (58)
Kidney cancer (19)
Labor market (97)
Layoffs (563)
Leadership (39)
Legal (7971)
Liver cancer (100)
Longevity (32)
Lung cancer (755)
Lymphoma (422)
Machine learning (59)
Management (59)
Manufacturing (1011)
MASH (183)
Medical device (13941)
Medtech (14049)
Mergers & acquisitions (20177)
Metabolic disorders (1474)
mRNA (199)
Multiple sclerosis (186)
NASH (17)
Neurodegenerative disease (407)
Neuropsychiatric disorders (104)
Neuroscience (3263)
Neurotech (1)
NextGen: Class of 2026 (6541)
Non-profit (4557)
Now hiring (76)
Obesity (689)
Opinion (285)
Ovarian cancer (212)
Pain (247)
Pancreatic cancer (291)
Parkinson's disease (355)
Partnered (33)
Patents (584)
Patient recruitment (655)
Peanut (61)
People (59804)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22071)
Phase 2 (31151)
Phase 3 (23181)
Pipeline (8080)
Policy (311)
Postmarket research (2573)
Preclinical (9404)
Press Release (68)
Prostate cancer (292)
Psychedelics (52)
Radiopharmaceuticals (319)
Rare diseases (1042)
Real estate (6027)
Recruiting (70)
Regulatory (25350)
Reports (55)
Research institute (2455)
Resumes & cover letters (355)
Rett syndrome (36)
RNA editing (20)
RSV (88)
Schizophrenia (176)
Series A (287)
Series B (210)
Service/supplier (11)
Sickle cell disease (109)
Special edition (22)
Spinal muscular atrophy (166)
Sponsored (47)
Startups (3661)
State (2)
Stomach cancer (18)
Supply chain (126)
Tariffs (88)
The Weekly (61)
Vaccines (1090)
Venture capital (105)
Weight loss (442)
Women's health (121)
Worklife (20)
Date
Today (226)
Last 7 days (875)
Last 30 days (3065)
Last 365 days (30327)
2026 (11069)
2025 (30219)
2024 (35256)
2023 (40136)
2022 (51244)
2021 (55807)
2020 (54206)
2019 (46686)
2018 (35173)
2017 (32277)
2016 (31672)
2015 (37786)
2014 (31481)
2013 (26557)
2012 (28755)
2011 (29438)
2010 (27552)
Location
Africa (745)
Alabama (92)
Alaska (7)
Arizona (344)
Arkansas (14)
Asia (39847)
Australia (6531)
California (12924)
Canada (3689)
China (1303)
Colorado (553)
Connecticut (560)
Delaware (395)
Europe (86185)
Florida (1940)
Georgia (416)
Hawaii (3)
Idaho (62)
Illinois (1032)
India (88)
Indiana (589)
Iowa (23)
Japan (518)
Kansas (130)
Kentucky (50)
Louisiana (40)
Maine (75)
Maryland (1556)
Massachusetts (9228)
Michigan (355)
Minnesota (700)
Mississippi (7)
Missouri (143)
Montana (33)
Nebraska (29)
Nevada (139)
New Hampshire (84)
New Jersey (3418)
New Mexico (28)
New York (3388)
North Carolina (1639)
North Dakota (8)
Northern California (6449)
Ohio (387)
Oklahoma (23)
Oregon (41)
Pennsylvania (2602)
Puerto Rico (28)
Rhode Island (50)
South America (1121)
South Carolina (85)
South Dakota (2)
Southern California (5099)
Tennessee (210)
Texas (2045)
United States (45688)
Utah (386)
Vermont (1)
Virginia (311)
Washington D.C. (80)
Washington State (1040)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
732,363 Results for "aruna biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Impact BioMedical Inc. Reports Going Concern Audit Opinion in 2025 10-K Filing While Continuing Strategic Merger Plans
April 5, 2026
·
1 min read
Genetown
Aruna Bio to Participate in Upcoming Investor Conferences
Aruna Bio, Inc. today announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at upcoming investor conferences.
March 18, 2024
·
1 min read
BioMidwest
Aruna Bio to Present at BIO International Convention 2024
Aruna Bio, Inc. announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the 2024 BIO International Convention being held June 3-6, 2024 at the San Diego Convention Center, California.
May 28, 2024
·
1 min read
Business
Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, announced the appointment of Lynn Swann to its Board of Directors.
June 3, 2024
·
2 min read
Press Releases
Breathe BioMedical Expands Multi-Center Clinical Study in Breast Cancer to Pittsburgh
Weinstein Imaging Associates joins as clinical site to collect breath samples to advance development of a breath test for early detection of breast cancer in women
May 5, 2026
·
5 min read
BioMidwest
Aruna BIO Establishes Stroke Advisory Board to Advance Lead Program, AB126 into the Clinic
Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative diseases, is pleased to announce the formation of its Stroke Advisory Board.
March 4, 2024
·
4 min read
Press Releases
Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit
April 8, 2026
·
1 min read
Press Releases
NBDF’s Pathway to Cures Announces Spark Biomedical’s LUNA Trial to Advance Non-Pharmaceutical Options for Heavy Menstrual Bleeding
March 25, 2026
·
4 min read
Press Releases
Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026
April 29, 2026
·
1 min read
Genetown
Aruna Bio to Participate in the BIO Investor Forum in October 2023
Aruna Bio, Inc. today announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the BIO Investor Forum being held October 17-18, 2023, in San Francisco, CA.
October 10, 2023
·
1 min read
1 of 73,237
Next
